ClearBridge Investments’s Blueprint Medicines BPMC Stock Holding History

ClearBridge Investments’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-405,708	Closed	-$52M	–	721
2025 Q2	$52M	Sell	405,708 -265,909	-40%	-$27.6M	0.04%	310
2025 Q1	$59.4M	Buy	671,617 +180,838	+37%	+$17.6M	0.05%	285
2024 Q4	$42.8M	Buy	490,779 +8,894	+2%	+$815K	0.03%	341
2024 Q3	$44.6M	Buy	481,885 +260,905	+118%	+$25.9M	0.04%	340
2024 Q2	$23.8M	Buy	+220,980	New	+$22.1M	0.02%	428

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ClearBridge Investments's BPMC Position: Q3 2025 in Review

ClearBridge Investments sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 405,708 shares — an estimated $52M sold.

ClearBridge Investments first reported a position in BPMC in Q2 2024 and held it in 5 quarters. The position peaked at $59.4M in Q1 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

ClearBridge Investments reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
ClearBridge Investments sold 405,708 Blueprint Medicines shares in Q3 2025, an estimated $52M.
ClearBridge Investments first reported a position in Blueprint Medicines in Q2 2024 and held it in 5 quarters.
ClearBridge Investments's Blueprint Medicines position peaked at $59.4M in Q1 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on ClearBridge Investments's 13F filing for Q3 2025, filed 13 Nov 2025.